Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Curis Inc (DE:CUSA)
FRANKFURT:CUSA
Curis (CUSA) Stock Price & Analysis
0 Followers
CUSA Stock Chart & Stats
Day’s Range€6.1 - €6.41
52-Week Range― - ―
Previous Close€7.26
Volume0.00
Average Volume (3M)N/A
Market Cap
$29.23M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Nov 07, 2023EPS Estimate
-€2.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€18.79Price Target Upside200.35% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Curis News
PremiumPress Releases
Curis Provides First Quarter 2023 Business Update
PremiumPre-Earnings
Curis Inc. (CRIS) Q1 Earnings Cheat SheetCUSA FAQ
What was Curis Inc’s price range in the past 12 months?
Currently, no data Available
What is Curis Inc’s market cap?
Currently, no data Available
When is Curis Inc’s upcoming earnings report date?
Curis Inc’s upcoming earnings report date is Nov 07, 2023 which is 177 days ago.
How were Curis Inc’s earnings last quarter?
Curis Inc released its earnings results on Aug 03, 2023. The company reported -€2.293 earnings per share for the quarter, missing the consensus estimate of -€2.254 by -€0.038.
Is Curis Inc overvalued?
According to Wall Street analysts Curis Inc’s price is currently Undervalued.
Does Curis Inc pay dividends?
Curis Inc does not currently pay dividends.
What is Curis Inc’s EPS estimate?
Curis Inc’s EPS estimate is -€2.22.
How many shares outstanding does Curis Inc have?
Currently, no data Available
What happened to Curis Inc’s price movement after its last earnings report?
Curis Inc reported an EPS of -€2.293 in its last earnings report, missing expectations of -€2.254. Following the earnings report the stock price went down -16.897%.
Which hedge fund is a major shareholder of Curis Inc?
Among the largest hedge funds holding Curis Inc’s share is Maverick Capital ltd. It holds Curis Inc’s shares valued at 5M.
---
Curis Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€18.79 (200.35% Upside)
€18.79 (200.35% Upside)
Blogger Sentiment
Bullish
DE:CUSA Sentiment 100%
Sector Average 68%
Sector Average 68%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-69.46%
12-Months-Change
Fundamentals
Return on Equity
-109.08%
Trailing 12-Months
Asset Growth
-34.56%
Trailing 12-Months
Company Description
Curis Inc
Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170, and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.
---
CUSA Stock 12 Months Forecast
Average Price Target
€18.79
▲(200.35% Upside)
Technical Analysis
Curis
―
Corvus Pharmaceuticals
―
Adaptimmune Therapeutics
―
G1 Therapeutics
―
Kura Oncology
―
Best Analysts Covering CUSA
1 Year
1 Year Success Rate
3/21 ratings generated profit
1 Year Average Return
+17.40%
assigned a buy rating 9 months ago
Copying Soumit Roy's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of +17.40% per trade.
---